Undervalued Small-Cap Healthcare Stocks on TSE April 2025

April 16, 2025

Healthcare Sector

The healthcare sector includes companies in biotechnology, pharmaceuticals, hospitals, home and long-term care. It also includes related medical equipment manufacturers and suppliers.

Toronto Stock Exchange

The Toronto Stock Exchange (TSE) is a stock exchange located in Toronto, Ontario, Canada. It is the 10th largest exchange in the world and the third largest in North America based on market capitalization.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Healthcare stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
ACB Aurora Cannabis - - 0.00 - 0 0.00 22.3
AIDX Healwell AI - - 0.00 - 0 0.00 0.0
AKU Akumin - - 0.00 - 0 0.00 0.0
APLI Appili Therapeutics - - 0.00 - 0 0.00 0.0
APS Aptose Biosciences - - 0.00 - 0 0.00 0.0
AVCN Avicanna - - 0.00 - 0 0.00 0.0
AVNT Avant Brands - - 0.00 - 0 0.00 0.0
BCT BriaCell Therapeutics - - 0.00 - 0 0.00 0.0
BHC Bausch Health Companies - - 0.00 - 0 0.00 0.0
BLCO Bausch & Lomb - - 0.00 - 0 0.00 0.0
All data provided as at market close April 15, 2025.

Company Details

Aurora Cannabis

ACB:TSX

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

22.3

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.

Access the stockcalc valuation


Healwell AI

AIDX:TSX

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Healwell AI Inc is a healthcare technology company focused on AI and data science for preventative care. The group's proprietary AI technology and competencies, including data science, electronic health records, and clinical research offerings, enable it is develop and commercialize clinical decision support systems. Its tools help healthcare providers detect rare and chronic diseases, improve the efficiency of their practice, and ultimately help improve patient health outcomes.

Access the stockcalc valuation


Akumin

AKU:TSX

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients.

Access the stockcalc valuation


Appili Therapeutics

APLI:TSX

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes programs namely ATI-1701, ATI-1801.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Aptose Biosciences

APS:TSX

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Access the stockcalc valuation


Avicanna

AVCN:TSX

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid advancements, it conducts most of its research in Canada at its research and development headquarters in JLABS in Toronto, located in the MaRS Discovery District.

Access the stockcalc valuation


Avant Brands

AVNT:TSX

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Avant Brands Inc is a premium cannabis company. It has multiple licensed and operational production facilities across Canada, which produce high-quality, handcrafted cannabis products for desired, and award-winning consumer brands, sold across both recreational and medical channels. The company's diverse product range is distributed through three distinct sales channels: recreational, medical, and export.

Access the stockcalc valuation


BriaCell Therapeutics

BCT:TSX

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy.

Access the stockcalc valuation


Bausch Health Companies

BHC:TSX

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Access the stockcalc valuation


Bausch & Lomb

BLCO:TSX

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Aurora Cannabis and Healwell AI are the most undervalued Small-Cap Healthcare stocks on the TSE. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-small-cap-healthcare-stocks-tse-april-2025
Aurora Cannabis $ACB and Healwell AI $AIDX are the most undervalued Healthcare stocks on the #TSE. See the full list: https://www.stockcalc.com/Blog/undervalued-small-cap-healthcare-stocks-tse-april-2025
Aurora Cannabis and Healwell AI are the most undervalued Small-Cap Healthcare stocks on the TSE. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-small-cap-healthcare-stocks-tse-april-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.